Solvoplex: A New Type of Synthetic Vector for Intrapulmonary Gene Delivery
- 10 December 1999
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 10 (18) , 2891-2905
- https://doi.org/10.1089/10430349950016311
Abstract
A novel type of synthetic vector, termed solvoplex, is described that can greatly enhance gene expression in lung after intrapulmonary delivery. Solvoplexes consist of plasmid DNA and organic solvents. Several organic solvents were analyzed, and luciferase reporter gene expression was observed after intrapulmonary delivery of solvoplexes containing DPSO (di-n-propylsulfoxide), TMU (tetramethylurea), or BMSO (butylmethylsulfoxide). Expression levels correlated with the amount of solvent used at constant DNA amounts. Highest expression was obtained in the lung after intratracheal injection with 15% DPSO resulting in an increase up to 440-fold compared with DNA alone. DPSO-solvoplexes (15%) gave higher reporter gene expression than polyplexes (ExGen 500) or lipoplexes (DOTAP-cholesterol or DOTAP-DOPE). Solvoplex-mediated gene expression did not depend on the delivery mode, and was observed in both mice and rats. Readministration of DPSO-solvoplexes was possible. A second injection after 4 weeks resulted in expression levels similar to the first administration. Histological analyses using lacZ and GFP reporter genes demonstrated gene expression in the lung airway epithelium after intratracheal and microspray delivery. When luciferase expression levels in lung homogenates were compared with adenovirus vectors, DPSO-solvoplexes were 4- or 100-fold less efficient, depending on the promoter used in the viral vector. A quantitative histological comparison between solvoplexes and adenovirus vectors in the best expressing regions revealed that solvoplexes yielded about 2% LacZ-positive cells in the lung airway epithelium, and adenovirus vectors about 20%. Using the microsprayer system, we demonstrated that DNA remained intact in solvoplexes on spraying and that reporter gene expression was observed in mice after intrapulmonary delivery of a solvoplex spray. DNA in DPSO-solvoplexes remained stable and functional after prolonged storage at room temperature.Keywords
This publication has 53 references indexed in Scilit:
- Efficiency of Cationic Lipid-Mediated Transfection of Polarized and Differentiated Airway Epithelial CellsIn VitroandIn VivoHuman Gene Therapy, 1998
- Vector-Specific Complementation Profiles of Two Independent Primary Defects in Cystic Fibrosis AirwaysHuman Gene Therapy, 1998
- Effects of Complement Depletion on the Pharmacokinetics and Gene Delivery Mediated by Cationic Lipid–DNA ComplexesHuman Gene Therapy, 1998
- ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivoGene Therapy, 1997
- Surfactant Inhibits Cationic Liposome-Mediated Gene TransferHuman Gene Therapy, 1997
- Intraluminal Water Increases Expression of Plasmid DNA in Rat LungHuman Gene Therapy, 1996
- The counterion influence on cationic lipid-mediated transfection of plasmid DNABiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- The spectrum of cystic fibrosis mutationsTrends in Genetics, 1992
- Widespread long-term gene transfer to mouse skeletal muscles and heart.Journal of Clinical Investigation, 1992
- Rapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene using a Liposome VehicleThe Lancet Healthy Longevity, 1989